Search research articles
Contact Us
Filters
Showing results (1-10 of 56) with videos related to
Page
of 6
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 25, 2025
C-Type Natriuretic Peptide: Protecting the Aorta
S Jeson Sangaralingham, John C Burnett
Circulation
|
December 21, 2018
Relaxing With C-Type Natriuretic Peptide, the Guanylyl Cyclase B Receptor, and Pericytes
S Jeson Sangaralingham, John C Burnett
Hypertension (Dallas, Tex. : 1979)
|
May 20, 2026
C-Type Natriuretic Peptide and Cardiovascular-Renal Protection in Sepsis
S Jeson Sangaralingham, John C Burnett
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
December 17, 2014
Urinary C-type natriuretic peptide: an emerging biomarker for heart failure and renal remodeling
Rosita Zakeri, John C Burnett, S Jeson Sangaralingham
European Heart Journal
|
March 26, 2019
C-type natriuretic peptide: the heart's guardian angel
S Jeson Sangaralingham, Yang Chen, John C Burnett
Molecular and Cellular Biochemistry
|
August 24, 2007
Estrogen delays the progression of salt-induced cardiac hypertrophy by influencing the renin-angiotensin system in heterozygous proANP gene-disrupted mice
S Jeson Sangaralingham, M Yat Tse, Stephen C Pang
The Journal of Endocrinology
|
June 27, 2007
Estrogen protects against the development of salt-induced cardiac hypertrophy in heterozygous proANP gene-disrupted mice
S Jeson Sangaralingham, M Yat Tse, Stephen C Pang
Current Heart Failure Reports
|
June 29, 2010
CD-NP: an innovative designer natriuretic peptide activator of particulate guanylyl cyclase receptors for cardiorenal disease
Paul M McKie, S Jeson Sangaralingham, John C Burnett
JACC. Heart Failure
|
September 13, 2015
Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides
Tomoko Ichiki, Brenda K Huntley, S Jeson Sangaralingham, et al.
Cardiovascular Research
|
August 25, 2022
Natriuretic peptide pathways in heart failure: further therapeutic possibilities
S Jeson Sangaralingham, Michaela Kuhn, Valentina Cannone, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 56) with videos related to
Sort By:
Page
of 6
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 25, 2025
C-Type Natriuretic Peptide: Protecting the Aorta
S Jeson Sangaralingham, John C Burnett
Circulation
|
December 21, 2018
Relaxing With C-Type Natriuretic Peptide, the Guanylyl Cyclase B Receptor, and Pericytes
S Jeson Sangaralingham, John C Burnett
Hypertension (Dallas, Tex. : 1979)
|
May 20, 2026
C-Type Natriuretic Peptide and Cardiovascular-Renal Protection in Sepsis
S Jeson Sangaralingham, John C Burnett
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
December 17, 2014
Urinary C-type natriuretic peptide: an emerging biomarker for heart failure and renal remodeling
Rosita Zakeri, John C Burnett, S Jeson Sangaralingham
European Heart Journal
|
March 26, 2019
C-type natriuretic peptide: the heart's guardian angel
S Jeson Sangaralingham, Yang Chen, John C Burnett
Molecular and Cellular Biochemistry
|
August 24, 2007
Estrogen delays the progression of salt-induced cardiac hypertrophy by influencing the renin-angiotensin system in heterozygous proANP gene-disrupted mice
S Jeson Sangaralingham, M Yat Tse, Stephen C Pang
The Journal of Endocrinology
|
June 27, 2007
Estrogen protects against the development of salt-induced cardiac hypertrophy in heterozygous proANP gene-disrupted mice
S Jeson Sangaralingham, M Yat Tse, Stephen C Pang
Current Heart Failure Reports
|
June 29, 2010
CD-NP: an innovative designer natriuretic peptide activator of particulate guanylyl cyclase receptors for cardiorenal disease
Paul M McKie, S Jeson Sangaralingham, John C Burnett
JACC. Heart Failure
|
September 13, 2015
Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides
Tomoko Ichiki, Brenda K Huntley, S Jeson Sangaralingham, et al.
Cardiovascular Research
|
August 25, 2022
Natriuretic peptide pathways in heart failure: further therapeutic possibilities
S Jeson Sangaralingham, Michaela Kuhn, Valentina Cannone, et al.
Page
of 6